Skip to main content
CDIO logo

Cardio Diagnostics Holdings, Inc.

CDIONASDAQHealthcareBiotechnology

$1.71Today:- (-)1Y −58.93%

As of Oct 16, 2026 close

Market cap
$5.21M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.97$7.91
Volume (live)
-
Avg. volume (3M)
31.77K

Cardio Diagnostics Holdings (CDIO) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Cardio Diagnostics Holdings used $5.73M of cash in operating activities and spent $187.32K on capital expenditures. That left free cash flow of −$5.91M.

Cardio Diagnostics Holdings Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Cardio Diagnostics Holdings, Inc. (CDIO) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-6.50-8.38-8.38-4.66-0.62-0.61
Depreciation & Amortization0.160.280.110.020.020.01
Stock Based Compensation0.112.591.280.000.060.59
Change in Working Capital0.260.520.21-0.56-0.040.03
Change in Accounts Receivable0.01-0.010.000.000.000.00
Change in Accounts Payable0.010.00-0.780.000.000.00
Change in Other Working Capital0.240.540.210.11-0.040.03
Other Operating Activities0.240.001.100.110.000.00
Net Cash from Operating Activities-5.73-4.99-5.67-5.09-0.590.03
Investing Activities
Capital Expenditures-0.19-0.40-0.58-0.08-0.11-0.03
Acquisitions0.000.000.000.14-0.250.00
Sales/Maturities of Investments0.000.00-0.200.000.000.00
Other Investing Activities-0.23-0.19-0.02-0.430.000.00
Net Cash from Investing Activities-0.42-0.40-0.79-0.37-0.36-0.03
Financing Activities
Debt Repayment-0.370.00-0.940.000.000.00
Common Stock Issued3.8012.550.3911.991.120.00
Other Financing Activities0.00-0.61-0.32-2.920.110.24
Net Cash from Financing Activities3.4311.943.639.061.230.24
Summary
Net Change in Cash-2.726.54-2.833.600.280.24
Cash at Beginning of Period7.831.284.120.510.240.00
Cash at End of Period5.117.831.284.120.510.24
Free Cash Flow-5.91-5.40-6.25-5.17-0.700.00
Supplemental Disclosures
Interest Paid-0.020.030.01--

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Cardio Diagnostics Holdings Cash Flow

What is Cardio Diagnostics Holdings's free cash flow?

Cardio Diagnostics Holdings had negative free cash flow of $5.91M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$5.73M minus $187.32K of capital expenditures.

How much does Cardio Diagnostics Holdings spend on capital expenditures?

Cardio Diagnostics Holdings spent $187.32K on capital expenditures in fiscal 2025, compared with $404.19K a year earlier.

Does Cardio Diagnostics Holdings pay dividends or buy back shares?

Cardio Diagnostics Holdings's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition